P09.07 The use of programmable shunts in patients treated with Tumor Treating Fields: Multicentric Case Series

OBJECTIVE: Tumor Treating Fields (TTFields) are a non-invasive, low intensity, intermediate frequency, alternating electric fields serving as anti-mitotic therapy for treatment of patients with newly diagnosed or recurrent glioblastoma multiforme (GBM). Recently, the Phase 3 EF-14 study demonstrated...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Schreiber, L., Rapp, M., Sabel, M., Onken, J., Misch, M., Kinzel, A., Thomé, C., Scholz, M., Vajkoczy, P., Freyschlag, C. F.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2017
Konular:
POSTER PRESENTATIONS
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5463837/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.265
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller